- Home
- YRD vs KALV Comparison
YRD vs KALV Comparison
Compare YRD & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YRD
- KALV
- Stock Information
- Founded
- YRD 2012
- KALV N/A
- Country
- YRD China
- KALV United States
- Employees
- YRD N/A
- KALV N/A
- Industry
- YRD Finance: Consumer Services
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- YRD Finance
- KALV Health Care
- Exchange
- YRD Nasdaq
- KALV Nasdaq
- Market Cap
- YRD 415.5M
- KALV 482.8M
- IPO Year
- YRD 2015
- KALV N/A
- Fundamental
- Price
- YRD $4.77
- KALV $8.86
- Analyst Decision
- YRD
- KALV Strong Buy
- Analyst Count
- YRD 0
- KALV 5
- Target Price
- YRD N/A
- KALV $27.67
- AVG Volume (30 Days)
- YRD 194.1K
- KALV 372.0K
- Earning Date
- YRD 11-20-2024
- KALV 12-24-2024
- Dividend Yield
- YRD 4.14%
- KALV N/A
- EPS Growth
- YRD N/A
- KALV N/A
- EPS
- YRD 2.95
- KALV N/A
- Revenue
- YRD $802,340,579.00
- KALV N/A
- Revenue This Year
- YRD N/A
- KALV N/A
- Revenue Next Year
- YRD N/A
- KALV N/A
- P/E Ratio
- YRD $1.62
- KALV N/A
- Revenue Growth
- YRD 19.51
- KALV N/A
- 52 Week Low
- YRD $2.94
- KALV $8.48
- 52 Week High
- YRD $9.20
- KALV $16.88
- Technical
- Relative Strength Index (RSI)
- YRD 43.26
- KALV 37.81
- Support Level
- YRD $4.66
- KALV $8.52
- Resistance Level
- YRD $4.93
- KALV $9.22
- Average True Range (ATR)
- YRD 0.31
- KALV 0.60
- MACD
- YRD 0.02
- KALV -0.04
- Stochastic Oscillator
- YRD 38.24
- KALV 10.50
About YRD Yiren Digital Ltd.
Yiren Digital Ltd is an advanced, AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.